Loading
The liver-cancer staging system that combines tumour size, liver function and fitness to recommend treatment: ablation or surgery, transplant, TACE, or drugs.
Barcelona Clinic Liver Cancer stages 0/A (very early/early: ablation, resection, transplant), B (intermediate: TACE, or systemic therapy for high burden), C (advanced: systemic therapy) and D (terminal). The 2022 update introduced treatment-stage migration and systemic therapy for some BCLC-B patients. Used in guidelines worldwide and as a trial-eligibility framework.
Showing the technology this term belongs to: Transarterial chemoembolisation (TACE).
Shares Portal vein tumour thrombus (macrovascular invasion), TACE (transarterial chemoembolisation), Transarterial chemoembolisation (TACE), Hepatocellular carcinoma.
Shares TACE (transarterial chemoembolisation), Transarterial chemoembolisation (TACE), Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma.
Shares Transarterial chemoembolisation (TACE), Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma.
Shares Transarterial chemoembolisation (TACE), Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma.
Shares TACE (transarterial chemoembolisation), Transarterial chemoembolisation (TACE), Thermal ablation (RFA, microwave, cryo), Hepatocellular carcinoma.
Shares Transarterial chemoembolisation (TACE), Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma.
Shares Transarterial chemoembolisation (TACE), Intermediate hepatocellular carcinoma (BCLC B), Hepatocellular carcinoma.
Shares Early hepatocellular carcinoma (BCLC 0 and A), Thermal ablation (RFA, microwave, cryo), Hepatocellular carcinoma.